跳转至内容
Merck
CN

SML2051

Sigma-Aldrich

LY2109761

≥98% (HPLC)

登录查看公司和协议定价

别名:
4-[5,6-二氢-2-(2-吡啶)-4H-吡咯[1,2-b]吡唑-3-基]-7-[2-(4-吗啉)乙氧基]-喹啉, LY-2109761
经验公式(希尔记法):
C26H27N5O2
分子量:
441.52
MDL编号:
UNSPSC代码:
12352200

检测方案

≥98% (HPLC)

形式

powder

颜色

white to beige

溶解性

DMSO: 2 mg/mL, clear

储存温度

−20°C

InChI

1S/C26H27N5O2/c1-2-9-27-22(4-1)26-25(24-5-3-11-31(24)29-26)21-8-10-28-23-18-19(6-7-20(21)23)33-17-14-30-12-15-32-16-13-30/h1-2,4,6-10,18H,3,5,11-17H2

InChI key

IHLVSLOZUHKNMQ-UHFFFAOYSA-N

应用

LY2109761可用作I型和II型转变生长因子- β(TGFβ)受体的抑制剂,以降低HepG2细胞中SMAD2(母体抗生物皮肤生长因子同源物)的磷酸化。

生化/生理作用

LY2109761抑制增生性瘢痕中转变生长因子(TGF)-β1-诱导成纤维细胞增殖和胶原合成。因此,它用于治疗增生性瘢痕。
Ly2109761是一种高效、口服活性TGF-β受体(TGFβR)I型&II型双重抑制剂(针对TGFβRI/ALK5和TGFβRII自磷酸化分别为IC50 = 70和322 nM,及4μM ATP),仅在达到更高浓度(20 μM时抑制58-89%)时抑制Fyn/JNK3/Lck/MKK6/SAPK2α并对其他37种激酶(IC50 >20 μM)表现出微弱效力甚至没有效力。LY2109761可在培养物中抑制0.25 ng/mL TGFβ诱导的NIH/3T3(IC50 = 210 nM;TGFβ前2小时预处理24小时)并且抑制人MX1乳腺癌异种移植瘤在小鼠体内的生长(第37天∼80%;第7天到第20天75 mg/kg,每日口服两次)。在转移性胰腺癌小鼠模型中,与吉西他滨联合用药(25 mg/kg/天,经腹腔注射)时,LY2109761(50 mg/kg,每日口服两次)可显著降低转移性胰腺癌小鼠模型中的肿瘤负荷和自发性腹腔转移。

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Xuan Liu et al.
BioMed research international, 2017, 2613198-2613198 (2017-03-17)
JPJD was an ideal alternative traditional Chinese medicine compound in the prevention and treatment of CRC, but its underlying mechanisms has not been fully elucidated. In this study, we demonstrated in vitro that TGF-β-induced EMT promoted the invasion and metastasis
Hong-Yu Li et al.
Journal of medicinal chemistry, 51(7), 2302-2306 (2008-03-05)
In our continuing effort to expand the SAR of the quinoline domain of dihydropyrrolopyrazole series, we have discovered compound 15d, which demonstrated the antitumor efficacy with oral bioavailability. This effort also demonstrated that the PK/PD in vivo target inhibition paradigm
Markus D Lacher et al.
Cancer research, 66(3), 1648-1657 (2006-02-03)
Expression of the Coxsackie and Adenovirus Receptor (CAR) is frequently reduced in carcinomas, resulting in decreased susceptibility of such tumors to infection with therapeutic adenoviruses. Because CAR participates physiologically in the formation of tight-junction protein complexes, we examined whether molecular
Jia Fang et al.
Scientific reports, 7, 43851-43851 (2017-03-04)
Previous studies have shown that CD61 (integrin-β3) promotes the differentiation of human umbilical cord mesenchymal stem cells (hUC-MSCs) into germ-like cells. However, the mechanism remains unclear. In this study, we showed that overexpression of CD61 in canine adipose-derived mesenchymal stem
Guo Wei et al.
Archives of dermatological research, 310(8), 615-623 (2018-07-27)
Hypertrophic scars (HS) are fibro-hyperproliferative dermal lesions with effusive continuous accumulation of extracellular matrix components, particularly collagen. They usually occur after dermal injury in genetically susceptible individuals and cause both physical and psychological distress for the affected individuals. Transforming growth

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门